alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Defense

###### Department of the Army

# AGENCY:

Department of the Army, DoD.

# ACTION:

Notice.

# SUMMARY:

Announcement is made of the availability for licensing of the invention set forth in U.S. Provisional Patent Application Serial No. 61/045,184 entitled “Novel Use and Method of Rapamycin to Treat Toxic Shock,” filed August 5, 2009. The United States Government, as represented by the Secretary of the Army, has rights to this invention.

# ADDRESSES:

Commander, U.S. Army Medical Research and Materiel Command, ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, Frederick, MD 21702-5012.

# FOR FURTHER INFORMATION CONTACT:

For patent issues, Ms. Elizabeth Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul Mele, Office of Research and Technology Assessment, (301) 619-6664, both at telefax (301) 619-5034.

# SUPPLEMENTARY INFORMATION:

                    The invention relates to the use of Rapamycin as a treatment of toxic shock                           ( print page 47930)                        induced by staphylococcal exotoxins; more specifically, staphylococcal enterotoxins that are potent activators for human T cells and can cause lethal shock.                

Brenda S. Bowen,

Army Federal Register Liaison Officer.

[FR Doc. E9-22554 Filed 9-17-09; 8:45 am]

BILLING CODE 3710-08-P
UNPUBLISHED

UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT

No. 21-6315

UNITED STATES OF AMERICA,

Plaintiff - Appellee,

v.

LESLIE EARLE ALVERSON,

Defendant - Appellant.

Appeal from the United States District Court for the District of South Carolina, at 

Greenville. Bruce H. Hendricks, District Judge. (6:17-cr-00074-BHH-1)

Submitted: May 14, 2021 Decided: May 21, 2021

Before NIEMEYER, KING, and THACKER, Circuit Judges.

Affirmed by unpublished per curiam opinion.

Leslie Earle Alverson, Appellant Pro Se. 

Unpublished opinions are not binding precedent in this circuit.
2

PER CURIAM:

Leslie Earle Alverson appeals the district court’s order denying his motion for 

compassionate release under 18 U.S.C. § 3582(c)(1)(A)(i). We review a district court’s 

denial of a motion for compassionate release for abuse of discretion. United States v. 

Kibble, 992 F.3d 326, 329 (4th Cir. 2021). We have reviewed the record and find no 

reversible error. Accordingly, we affirm for the reasons stated by the district court. 

United States v. Alverson, No. 6:17-cr-00074-BHH-1 (D.S.C. Feb. 16, 2021). 

See United States v. High, __ F.3d __, 2021 WL 1823289 (4th Cir. May 7, 2021) (holding 

that the district court need not expressly address each of the movant’s arguments, but must 

provide a sufficient explanation to allow for meaningful appellate review of its decision). 

We dispense with oral argument because the facts and legal contentions are adequately 

presented in the materials before this court and argument would not aid the decisional 

process.

AFFIRMED
§ 438.500 Definitions. ( a ) Definitions. As used in this subpart, the following terms have the indicated meanings:
*Measurement period* means the period for which data are collected for a measure or the performance period that a measure covers.
*Measurement year* means the first calendar year and each calendar year thereafter for which a full calendar year of claims and encounter data necessary to calculate a measure are available.
*Medicaid managed care quality rating system framework (QRS framework)* means the mandatory measure set identified by CMS in the Medicaid and CHIP managed care quality rating system technical resource manual described in § 438.530, the methodology for calculating quality ratings described in § 438.515, and the website display described in § 438.520 of this subpart.
*Medicare Advantage and Part D 5-Star Rating System (MA and Part D quality rating system)* means the rating system described in subpart D of parts 422 and 423 of this chapter.
*Qualified health plan quality rating system (QHP quality rating system)* means the health plan quality rating system developed in accordance with 45 CFR 156.1120.
*Quality rating* means the numeric or other value of a quality measure or an assigned indicator that data for the measure is not available.
*Technical resource manual* means the guidance described in § 438.530.
*Validation* means the review of information, data, and procedures to determine the extent to which they are accurate, reliable, free from bias, and in accord with standards for data collection and analysis.
§ 484.75 Condition of participation: Skilled professional services. Skilled professional services include skilled nursing services, physical therapy, speech-language pathology services, and occupational therapy, as specified in § 409.44 of this chapter, and physician or allowed practitioner and medical social work services as specified in § 409.45 of this chapter. Skilled professionals who provide services to HHA patients directly or under arrangement must participate in the coordination of care. ( a ) *Standard: Provision of services by skilled professionals.* Skilled professional services are authorized, delivered, and supervised only by health care professionals who meet the appropriate qualifications specified under § 484.115 and who practice according to the HHA's policies and procedures.
( b ) *Standard: Responsibilities of skilled professionals.* Skilled professionals must assume responsibility for, but not be restricted to, the following: ( 1 ) Ongoing interdisciplinary assessment of the patient;
( 2 ) Development and evaluation of the plan of care in partnership with the patient, representative (if any), and caregiver(s);
( 3 ) Providing services that are ordered by the physician or allowed practitioner as indicated in the plan of care;
( 4 ) Patient, caregiver, and family counseling;
( 5 ) Patient and caregiver education;
( 6 ) Preparing clinical notes;
( 7 ) Communication with all physicians involved in the plan of care and other health care practitioners (as appropriate) related to the current plan of care;
( 8 ) Participation in the HHA's QAPI program; and
( 9 ) Participation in HHA-sponsored in-service training.
( c ) *Supervision of skilled professional assistants.* ( 1 ) Nursing services are provided under the supervision of a registered nurse that meets the requirements of § 484.115(k).
( 2 ) Rehabilitative therapy services are provided under the supervision of an occupational therapist or physical therapist that meets the requirements of § 484.115(f) or (h), respectively.
( 3 ) Medical social services are provided under the supervision of a social worker that meets the requirements of § 484.115(m).
[82 FR 4578, Jan. 13, 2017, as amended at 85 FR 27628, May 8, 2020]
Exhibit 32.2

CERTIFICATION PURSUANT TO

SECTION 1350, CHAPTER 63 OF TITLE 18, UNITED STATES CODE,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

 

Pursuant to Section 1350, Chapter 63 of Title 18, United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned, as Chief Financial Officer of Owl Rock Core Income Corp. (the “Company”), does hereby certify that to the undersigned’s knowledge:

 

1) the Company’s Form 10-K for the year ended December 31, 2021 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

2) the information contained in the Company’s Form 10-K for the year ended December 31, 2021 fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

 

|                     |        |        |                         |
|---------------------|--------|--------|-------------------------|
| Date: March 9, 2022 |   | By:    | /s/ Bryan Cole          |
|                |   |   | Bryan Cole              |
|                |   |   | Chief Financial Officer |

 

 

 

----
EXHIBIT 32





CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002





The undersigned have executed this certification in connection with the filing with the Securities and Exchange Commission of the Company’s Quarterly Report on Form 10-Q for the period ending June 30, 2009. The undersigned hereby certify that to our knowledge:





(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and





(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.








Dated:   August 13, 2009
/s/Raul S. McQuiveyRaul S. McQuiveyPresident and Chief Executive Officer(Principal Executive Officer)Dated:   August 13, 2009
/s/Sidney C. HooperSidney C. HooperChief Financial Officer(Principal Accounting Officer)
§ 489.34 Allowable charges: Hospitals participating in State reimbursement control systems or demonstration projects. A hospital receiving payment for a covered hospital stay under either a State reimbursement control system approved under 1886(c) of the Act or a demonstration project authorized under section 402(a) of Pub. L. 90-248 (42 U.S.C. 1395b-1) or section 222(a) of Pub. L. 92-603 (42 U.S.C. 1395b-1 (note)) and that would otherwise be subject to the prospective payment system set forth in part 412 of this chapter may charge a beneficiary for noncovered services as follows: ( a ) For the custodial care and medically unnecessary services described in § 412.42(c) of this chapter, after the conditions of § 412.42(c)(1) through (c)(4) are met; and
( b ) For all other services in accordance with the applicable rules of this subpart C.
[54 FR 41747, Oct. 11, 1989]
IN THE SUPREME COURT OF PENNSYLVANIA

MIDDLE DISTRICT

COMMONWEALTH OF PENNSYLVANIA,

Respondent

v.

DOUGLAS BITZER,

Petitioner

:

:

:

:

:

:

:

:

:

:

:

No. 828 MAL 2017

Petition for Allowance of Appeal from 

the Order of the Superior Court

ORDER

PER CURIAM

AND NOW, this 2nd day of May, 2018, the Petition for Allowance of Appeal is 

DENIED.
**Exhibit 31(a)****CERTIFICATION PURSUANT TO RULE 13a-14(a) and 15d-14(a)**I, Gregory B. Kalush, certify that:1. I have reviewed this report on Form 10-Q of Interphase Corporation (the “Company”); 2. Based on my knowledge, this report does not contain any untrue statement of a materialfact or omit to state a material fact necessary to make the statements made, in light of thecircumstances under which such statements were made, not misleading with respect to the periodcovered by this report; 3. Based on my knowledge, the financial statements, and other financial information includedin this report, fairly present in all material respects the financial condition, results ofoperations and cash flows of the Company as of, and for, the periods presented in this report; 4. The Company’s other certifying officer and I are responsible for establishing andmaintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and15d-15(e)) for the Company and we have:(a) Designed such disclosure controls and procedures, or caused such disclosure controls andprocedures to be designed under our supervision, to ensure that material information relating tothe Company, including its consolidated subsidiaries, is made known to us by others within thoseentities, particularly during the period in which this report is being prepared;(b) Evaluated the effectiveness of the Company’s disclosure controls and procedures andpresented in this report our conclusions about the effectiveness of the disclosure controls andprocedures as of the end of the period covered by this report based on such evaluation; and(c) Disclosed in this report any change in the Company’s internal control over financialreporting that occurred during the Company’s most recent fiscal quarter that has materiallyaffected, or is reasonably likely to materially affect, the Company’s internal control overfinancial reporting; and5. The Company’s other certifying officer and I have disclosed, based on our most recentevaluation of internal control over financial reporting, to the Company’s auditors and theAudit Committee of the Company’s Board of Directors:(a) All significant deficiencies and material weaknesses in the design or operation of internalcontrol over financial reporting which are reasonably likely to adversely affect the Company’sability to record, process, summarize and report financial information; and(b) Any fraud, whether or not material, that involves management or other employees who have asignificant role in the Company’s internal control over financial reporting.     Date: November 14, 2005 Signature: /s/ Gregory B. Kalush         Chief Executive Officer
HomeReports – U.S. Advisory Commission on Public Diplomacy...Public Diplomacy at Risk: Protecting Open Access for American Centers (2015)

# 									Public Diplomacy at Risk: Protecting Open Access for American Centers (2015)							

ACPD Special Report

May 5, 2015

Public Diplomacy at Risk: Protecting Open Access for American Centers

Tags

Advisory CommitteePublic DiplomacyU.S. Advisory Commission on Public Diplomacy

Back to Top
Editorial Note on Part 84
Editorial Note: Nomenclature changes to part 84 appear at 69 FR 18803, Apr. 9, 2004.

§ 84.252 Gas masks; requirements and tests. ( a ) Except for the tests prescribed in § 84.126, the minimum requirements and performance tests for gas masks, prescribed in Subpart I of this part, are applicable to vinyl chloride gas masks.
( b ) The following bench tests are applicable to canisters designed for use with gas masks for entry into and escape from vinyl chloride atmospheres containing adequate oxygen to support life: ( 1 ) Four canisters will be equilibrated at 25 ±5 °C by passing 85 ±5 percent relative humidity air through them at 64 liters per minute for six hours.
( 2 ) The equilibrated canisters will be resealed, kept in an upright position at room temperature, and tested according to paragraph (b)(3) of this section within 18 hours.
( 3 ) The canisters equilibrated and stored as described in paragraphs (b) (1) and (2) of this section will be tested on an apparatus that allows the test atmosphere at 85 ±5 percent relative humidity and 25 ±5 °C to enter the canister continuously at a concentration of 25 ppm vinyl chloride monomer at a total flow rate of 64 liters per minute.
( 4 ) The maximum allowable penetration after six hours of testing according to paragraph (b)(3) of this section shall not exceed 1 ppm vinyl chloride.
( c ) Where canisters are submitted for testing and approval with a service life of more than four hours, the period of time for testing for vinyl chloride penetration will be performed at 150% of the service life specified in the manufacturer's application. (Example: If a manufacturer requests approval of a respirator for six hours use against exposure to vinyl chloride, the maximum allowable penetration after nine hours of testing shall not exceed 1 ppm vinyl chloride.)
<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
     IMTEC, Inc., EX-27, FDS for 10-Q, December 31, 1999
</LEGEND>
<CIK>                         0000730045
<NAME>                        IMTEC, Inc.
<MULTIPLIER>                                   1
<CURRENCY>                                     US

<S>                             <C>
<PERIOD-TYPE>                   6-mos
<FISCAL-YEAR-END>                              JUN-30-2000
<PERIOD-START>                                 JUL-01-1999
<PERIOD-END>                                   DEC-31-1999
<EXCHANGE-RATE>                                1
<CASH>                                         107091
<SECURITIES>                                   0
<RECEIVABLES>                                  3010725
<ALLOWANCES>                                   276600
<INVENTORY>                                    2360976
<CURRENT-ASSETS>                               5580827
<PP&E>                                         10787212
<DEPRECIATION>                                 4843782
<TOTAL-ASSETS>                                 11524257
<CURRENT-LIABILITIES>                          1868290
<BONDS>                                        1969179
<PREFERRED-MANDATORY>                          0
<PREFERRED>                                    0
<COMMON>                                       16330
<OTHER-SE>                                     2725450
<TOTAL-LIABILITY-AND-EQUITY>                   7567420
<SALES>                                        7530143
<TOTAL-REVENUES>                               7530143
<CGS>                                          4428062
<TOTAL-COSTS>                                  4428062
<OTHER-EXPENSES>                               2268036
<LOSS-PROVISION>                               276600
<INTEREST-EXPENSE>                             30539
<INCOME-PRETAX>                                803602
<INCOME-TAX>                                   302877
<INCOME-CONTINUING>                            500725
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   500725
<EPS-BASIC>                                    0.30
<EPS-DILUTED>                                  0.30



</TABLE>
|Rank this query?Records: 22203
                                                Hits: 0 |                                                                        |                  |                  | Rank this query? | Rank this query? | Records: 22203
                                                Hits: 0 | Records: 22203
                                                Hits: 0 | Records: 22203 | Hits: 0 |  |  |  |  |  |  | 
|-------------------------------------------------------------------------------------- | ---------------------------------------------------------------------- | ---------------- | ---------------- | ---------------- | ---------------- | ---------------------------------------------------------------------- | ---------------------------------------------------------------------- | -------------- | ------- |  |  |  |  |  |  | 
|                                                                                       |                                                                        | Rank this query? | Rank this query?
|Rank this query?                                                                      
|Records: 22203
                                                Hits: 0                 | Records: 22203
                                                Hits: 0 | Records: 22203   | Hits: 0          |                  |                  |                                                                        |                                                                        |                |         | 
|Records: 22203
                                                Hits: 0                 | Records: 22203                                                         | Hits: 0          |                  |                  |                  |                                                                        |                                                                       
|Records: 22203                                                                         | Hits: 0
**Secondary Market Report**
**January 1999**
TABLE 2
HomeOffice of the SpokespersonPublic Schedule...Public Schedule – October 19, 2021

# 									Public Schedule – October 19, 2021							

Public Schedule

Office of the Spokesperson

October 19, 2021

*****THE DAILY PUBLIC SCHEDULE IS SUBJECT TO CHANGE*****

**SECRETARY ANTONY J. BLINKEN**

Secretary Blinken is on travel to Ecuador and Colombia, from October 19-21, 2021.  Please click here for more information.

**2:00 p.m. LOCAL** Secretary Blinken attends a Working Lunch Ecuadorian President Guillermo Lasso and Foreign Minister Mauricio Montalvo, in Quito, Ecuador.**(POOLED CAMERA SPRAY AT TOP)**

**3:25 p.m. LOCAL** Secretary Blinken holds a Joint Press Availability with Ecuadorian Foreign Minister Mauricio Montalvo, in Quito, Ecuador.**(POOLED PRESS COVERAGE)**

**4:45 p.m. LOCAL**Secretary Blinken participates in a Small and Medium-Sized Enterprise Event, in Quito, Ecuador.**(POOLED PRESS COVERAGE)**

**5:45 p.m. LOCAL** Secretary Blinken holds a Meet and Greet with U.S. Mission Ecuador, in Quito, Ecuador.**(POOLED PRESS COVERAGE FOR OPENING REMARKS)**

**6:25 p.m. LOCAL** Secretary Blinken holds a Democracy and Civil Society Roundtable, in Quito, Ecuador.**(POOLED PRESS COVERAGE FOR OPENING REMARKS)**

**DEPUTY SECRETARY WENDY R. SHERMAN**

Deputy Secretary Sherman attends meetings and briefings, from the Department of State.

**DEPUTY SECRETARY FOR MANAGEMENT AND RESOURCES BRIAN P. MCKEON**

Deputy Secretary McKeon attends meetings and briefings, from the Department of State.

**UNDER SECRETARY FOR POLITICAL AFFAIRS VICTORIA J. NULAND**

Under Secretary Nuland attends meetings and briefings, from the Department of State.

**ASSISTANT SECRETARY FOR AFRICAN AFFAIRS MOLLY PHEE**

Assistant Secretary Phee is on travel to Ghana and Burkina Faso, from October 16-21, 2021. Please click here for more information.

**BRIEFING SCHEDULE**

No Department Press Briefing

Tags

Office of the SpokespersonThe Secretary of State

Back to Top